These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10662558)

  • 41. [Screening of blood donors for anti-HIV-1].
    Peichl-Hoffmann G
    Beitr Infusionsther; 1990; 26():15-7. PubMed ID: 1703816
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predonation screening of candidate donors and prevention of window period donations.
    Lieshout-Krikke RW; Zaaijer HL; van de Laar TJ
    Transfusion; 2015 Feb; 55(2):373-8. PubMed ID: 25130605
    [TBL] [Abstract][Full Text] [Related]  

  • 43. AIDS and HIV infection in the United Kingdom: monthly report.
    Commun Dis Rep CDR Wkly; 1999 Sep; 9(39):353-4. PubMed ID: 10510564
    [No Abstract]   [Full Text] [Related]  

  • 44. HIV transmissions from a window-period platelet donation.
    Kopko PM; Fernando LP; Bonney EN; Freeman JL; Holland PV
    Am J Clin Pathol; 2001 Oct; 116(4):562-6. PubMed ID: 11601141
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transmission of HIV infection by seronegative blood in Thailand.
    Isarangkura P; Chiewsilp P; Tanprasert S; Nuchprayoon C
    J Med Assoc Thai; 1993 Oct; 76 Suppl 2():106-13. PubMed ID: 7822978
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estimated risk of HIV transmission by blood transfusion in Kenya.
    Moore A; Herrera G; Nyamongo J; Lackritz E; Granade T; Nahlen B; Oloo A; Opondo G; Muga R; Janssen R
    Lancet; 2001 Aug; 358(9282):657-60. PubMed ID: 11530174
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nucleic acid amplification testing detection of an HIV-1 infection in a blood donor during the preseroconversion window period.
    Piquet Y; Ivanovic Z; Laperche S; Pillonel J; Cristol G; Jeanne M; Neau D; Fleury H; Boiron JM
    Transfus Med; 2007 Apr; 17(2):147-8. PubMed ID: 17430474
    [No Abstract]   [Full Text] [Related]  

  • 48. Genomic detection of human immunodeficiency virus (HIV) by nucleic acid amplification test in a frequent platelet donor during the pre-seroconversion period.
    Pondé RA
    Arch Virol; 2011 Nov; 156(11):2085-90. PubMed ID: 21842160
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serological and molecular screening for viruses in blood donors from Ntcheu, Malawi: high prevalence of HIV-1 subtype C and of markers of hepatitis B and C viruses.
    Candotti D; Mundy C; Kadewele G; Nkhoma W; Bates I; Allain JP
    J Med Virol; 2001 Sep; 65(1):1-5. PubMed ID: 11505436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Screening for markers of transfusion-associated infections in autologous blood donation].
    Zimmermann R; Schwella N; Weissbach V; Heuft HG; Eckstein R
    Beitr Infusionsther Transfusionsmed; 1994; 32():488-91. PubMed ID: 9480148
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A retrospective study of the practice of "look-back" procedures, on the incidence of HIV-1/2-positive blood donors and the risk of transfusion-associated HIV infection in public-community blood banks in Germany].
    Zeiler T; Kretschmer V; Sibrowski W
    Infusionsther Transfusionsmed; 1994 Dec; 21(6):362-7. PubMed ID: 7873914
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Screening of donor blood for anti-HIV. Experiences from blood donor screening 1986-1988].
    Schmidt KW; Dickmeiss E
    Nord Med; 1990; 105(12):331-4. PubMed ID: 2270198
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Twenty-seven year surveillance of blood transfusion recipients infected with HIV-1 in Hebei Province, China.
    Chen S; Lu X; Bai G; Zhang Y; Li B; Wang W; Liang L; Ma L; Li Y; Wang X; Wang Y; Zhao C; Zhao H
    PLoS One; 2018; 13(8):e0202265. PubMed ID: 30110373
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of unreported HIV prophylaxis on the kinetics of post-blood donation HIV seroconversion.
    Nishiya AS; Salles NA; de Almeida-Neto C; Witkin SS; Ferreira SC; Nogueira FAH; Facincani T; Rocha V; Mendrone-Jr A
    Transfusion; 2021 Dec; 61(12):3488-3492. PubMed ID: 34617611
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of unreported usage of the antiretroviral drug lamivudine in two blood donors.
    Nishiya A; Salles N; de Almeida-Neto C; Ferreira S; Nogueira F; Rocha V; Mendrone-Júnior A
    Transfusion; 2023 Nov; 63(11):2106-2113. PubMed ID: 37702479
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Testing blood donors for HIV: current controversies.
    Busch MP
    Immunol Invest; 1995; 24(1-2):147-54. PubMed ID: 7713578
    [TBL] [Abstract][Full Text] [Related]  

  • 57. No need for bad blood over bad blood.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2015 May; 15(5):487. PubMed ID: 25932570
    [No Abstract]   [Full Text] [Related]  

  • 58. [Autologous blood donation--good clinical practice and good recuperation practice].
    Hauser SP; Otth C; Franscini L; Nydegger UE
    Schweiz Med Wochenschr; 1996 Nov; 126(46):1970-4. PubMed ID: 8984605
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The long shadows of past mistakes.
    Lancet HIV
    Lancet HIV; 2015 Feb; 2(2):e33. PubMed ID: 26424455
    [No Abstract]   [Full Text] [Related]  

  • 60. The risk is in the transfusion, not the donation.
    Sher G
    CMAJ; 1998 May; 158(10):1266. PubMed ID: 9614814
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.